S&P 500 Futures
(0.17%) 5 336.25 points

Dow Jones Futures
(0.08%) 40 170 points

Nasdaq Futures
(0.25%) 18 683 points

Oil
(-0.54%) $79.63

Gas
(2.02%) $2.68

Gold
(0.43%) $2 427.90

Silver
(0.69%) $31.48

Platinum
(-1.27%) $1 076.20

USD/EUR
(0.12%) $0.921

USD/NOK
(0.20%) $10.70

USD/GBP
(0.08%) $0.788

USD/RUB
(-0.32%) $90.68

Realtime updates for Oncimmune Holdings PLC [ONC.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences

Last Updated17 May 2024 @ 08:29

25% discount on Stockinvest.us - Use code: Podcast

0.00% £ 24.50

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 08:29):

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally...

Stats
Today's Volume	6 355.00
Average Volume	74 312.00
Market Cap	18.16M
EPS	£0 ( 2023-09-28 )
Next earnings date	( £0 ) 2024-05-29
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-3.06
ATR14	£0 (0.00%)

Oncimmune Holdings PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oncimmune Holdings PLC Financials

Annual	2022
Revenue:	£1.15M
Gross Profit:	£792 000 (68.75 %)
EPS:	£0.0565

FY	2022
Revenue:	£1.15M
Gross Profit:	£792 000 (68.75 %)
EPS:	£0.0565

FY	2022
Revenue:	£3.86M
Gross Profit:	£1.46M (37.76 %)
EPS:	£-0.140

FY	2021
Revenue:	£3.72M
Gross Profit:	£2.86M (76.76 %)
EPS:	£-0.0717

Financial Reports:

No articles found.

Oncimmune Holdings PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Oncimmune Holdings PLC

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.